The manager of a table-topping biotechnology trust has said careful use of the closed-ended structure has enabled him to outperform, including holding half of his assets in just five stocks.
Daniel Koller, who leads the management team for the BB Biotech trust, said that the independence of the closed-ended structure allowed him to take significant positions of 10% or more in selected stocks....
The US dollar is close to peaking and the risks now seem to be on the downside.
Latest news and analysis
Fallout from Haywood suspension
Songs from writers Johntá Austin, Sean Garrett and Rico Love
Strategic public equity